Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_provenance.
- NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_provenance.
- NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_assertion evidence source_evidence_literature NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_provenance.
- NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_assertion SIO_000772 21288594 NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_provenance.
- NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_assertion wasDerivedFrom befree-20140225 NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_provenance.
- NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_assertion wasGeneratedBy ECO_0000203 NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_provenance.
- befree-20140225 importedOn "2014-02-25" NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_provenance.